BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24092654)

  • 1. A founder SDHB mutation in Portuguese paraganglioma patients.
    Martins RG; Nunes JB; Máximo V; Soares P; Peixoto J; Catarino T; Rito T; Soares P; Pereira L; Sobrinho-Simões M; Santos AP; Couto J; Henrique R; Matos-Loureiro J; Dias P; Torres I; Lima J
    Endocr Relat Cancer; 2013 Dec; 20(6):L23-6. PubMed ID: 24092654
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
    Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
    Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma.
    Gimm O; Armanios M; Dziema H; Neumann HP; Eng C
    Cancer Res; 2000 Dec; 60(24):6822-5. PubMed ID: 11156372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No child left behind in SDHB testing for paragangliomas and pheochromocytomas.
    Schiffman JD
    J Clin Oncol; 2011 Nov; 29(31):4070-2. PubMed ID: 21969491
    [No Abstract]   [Full Text] [Related]  

  • 7. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.
    Rijken JA; Niemeijer ND; Jonker MA; Eijkelenkamp K; Jansen JC; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; Kerstens MN; Dreijerink KMA; van Dooren MF; van der Horst-Schrivers ANA; Hes FJ; Leemans CR; Corssmit EPM; Hensen EF
    Clin Genet; 2018 Jan; 93(1):60-66. PubMed ID: 28503760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
    Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
    Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.
    Rusyn L; Kohn B
    Pediatr Endocrinol Rev; 2017 Mar; 14(3):312-325. PubMed ID: 28508602
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
    Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.
    Hensen EF; van Duinen N; Jansen JC; Corssmit EP; Tops CM; Romijn JA; Vriends AH; van der Mey AG; Cornelisse CJ; Devilee P; Bayley JP
    Clin Genet; 2012 Mar; 81(3):284-8. PubMed ID: 21348866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations.
    King KS; Prodanov T; Kantorovich V; Fojo T; Hewitt JK; Zacharin M; Wesley R; Lodish M; Raygada M; Gimenez-Roqueplo AP; McCormack S; Eisenhofer G; Milosevic D; Kebebew E; Stratakis CA; Pacak K
    J Clin Oncol; 2011 Nov; 29(31):4137-42. PubMed ID: 21969497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.
    Jochmanova I; Wolf KI; King KS; Nambuba J; Wesley R; Martucci V; Raygada M; Adams KT; Prodanov T; Fojo AT; Lazurova I; Pacak K
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1421-1435. PubMed ID: 28374168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?
    Cascón A; Montero-Conde C; Ruiz-Llorente S; Mercadillo F; Letón R; Rodríguez-Antona C; Martínez-Delgado B; Delgado M; Díez A; Rovira A; Díaz JA; Robledo M
    Genes Chromosomes Cancer; 2006 Mar; 45(3):213-9. PubMed ID: 16258955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel SDHD germ-line mutations in pheochromocytoma patients.
    Neumayer C; Moritz A; Asari R; Weinhäusel A; Hölzenbein T; Kretschmer G; Niederle B; Haas OA
    Eur J Clin Invest; 2007 Jul; 37(7):544-51. PubMed ID: 17576205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.
    Klein RD; Jin L; Rumilla K; Young WF; Lloyd RV
    Diagn Mol Pathol; 2008 Jun; 17(2):94-100. PubMed ID: 18382370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients.
    Bayley JP; Grimbergen AE; van Bunderen PA; van der Wielen M; Kunst HP; Lenders JW; Jansen JC; Dullaart RP; Devilee P; Corssmit EP; Vriends AH; Losekoot M; Weiss MM
    BMC Med Genet; 2009 Apr; 10():34. PubMed ID: 19368708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K40E: a novel succinate dehydrogenase (SDH)B mutation causing familial phaeochromocytoma and paraganglioma.
    McDonnell CM; Benn DE; Marsh DJ; Robinson BG; Zacharin MR
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):510-4. PubMed ID: 15473885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma.
    Assadipour Y; Sadowski SM; Alimchandani M; Quezado M; Steinberg SM; Nilubol N; Patel D; Prodanov T; Pacak K; Kebebew E
    Surgery; 2017 Jan; 161(1):230-239. PubMed ID: 27839933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SDHB mutation analysis in familial and sporadic phaeochromocytoma identifies a novel mutation.
    Cascón A; Cebrián A; Ruiz-Llorente S; Tellería D; Benítez J; Robledo M
    J Med Genet; 2002 Oct; 39(10):E64. PubMed ID: 12362046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.